Prevalence of SARS-CoV-2 infection in the Luxembourgish population – the CON-VINCE study

Chantal J. Snoeck, Michel Vaillant, Tamir Abdelrahman, Venkata P. Satagopam, Jonathan D. Turner, Katy Beaumont, Clarissa P. C. Gomes, Joëlle V. Fritz, Valerie E. Schröder, Anne Kaysen, Lukas Pavelka, Lara Stute, Guilherme Ramos Meyers, Laure Pauly, Maxime Hansen, Claire Pauly, Gloria A. Aguayo, Magali Perquin, Anne-Marie Hanff, Soumyabrata Ghosh, Manon Gantenbein, Laetitia Huiart, Markus Ollert, Rejko Krüger on behalf of the CON-VINCE study group
doi: https://doi.org/10.1101/2020.05.11.20092916

Article Information

doi 
https://doi.org/10.1101/2020.05.11.20092916
History 
  • May 18, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Chantal J. Snoeck1,*,
  2. Michel Vaillant8,*,
  3. Tamir Abdelrahman9,*,
  4. Venkata P. Satagopam7,12,
  5. Jonathan D. Turner1,
  6. Katy Beaumont5,
  7. Clarissa P. C. Gomes3,
  8. Joëlle V. Fritz4,
  9. Valerie E. Schröder2,3,
  10. Anne Kaysen3,
  11. Lukas Pavelka2,3,
  12. Lara Stute2,3,
  13. Guilherme Ramos Meyers3,
  14. Laure Pauly3,
  15. Maxime Hansen2,4,
  16. Claire Pauly2,3,
  17. Gloria A. Aguayo6,
  18. Magali Perquin6,
  19. Anne-Marie Hanff4,
  20. Soumyabrata Ghosh7,
  21. Manon Gantenbein10,
  22. Laetitia Huiart6,
  23. Markus Ollert1,12,x,
  24. Rejko Krüger2,4,7,x,† and
  25. on behalf of the CON-VINCE study group
  1. 1Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, L-4354 Luxembourg
  2. 2Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, L-1210
  3. 3Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg
  4. 4Transversal Translational Medicine, Luxembourg Institute of Health, Strassen, Luxembourg
  5. 5Integrated Biobank of Luxembourg (IBBL), Dudelange, L-3555 Luxembourg
  6. 6Population Health Department, Luxembourg Institute of Health. Strassen L-1445 Luxembourg
  7. 7Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg
  8. 8Competence Center for Methodology and Statistics, Luxembourg Institute of Health. Strassen L-1445 Luxembourg
  9. 9Department of Microbiology, Laboratoire national de santé, Dudelange, L-3555, Luxembourg
  10. 10Clinical and Epidemiological Investigation Center (CIEC), Luxembourg Institute of Health. Strassen L-1445 Luxembourg
  11. 11Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, University of Southern Denmark, Odense C, Denmark
  12. 12ELIXIR-Luxembourg Node, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg
  1. ↵†Corresponding author: rejko.krueger{at}lih.lu

  1. ↵* co-first authors

  2. ↵x co-senior authors

  3. ↵# (all study group members are listed in the acknowledgment part)

Back to top
Posted May 18, 2020.
Download PDF
Data/Code
Email
Prevalence of SARS-CoV-2 infection in the Luxembourgish population – the CON-VINCE study
Chantal J. Snoeck, Michel Vaillant, Tamir Abdelrahman, Venkata P. Satagopam, Jonathan D. Turner, Katy Beaumont, Clarissa P. C. Gomes, Joëlle V. Fritz, Valerie E. Schröder, Anne Kaysen, Lukas Pavelka, Lara Stute, Guilherme Ramos Meyers, Laure Pauly, Maxime Hansen, Claire Pauly, Gloria A. Aguayo, Magali Perquin, Anne-Marie Hanff, Soumyabrata Ghosh, Manon Gantenbein, Laetitia Huiart, Markus Ollert, Rejko Krüger
medRxiv 2020.05.11.20092916; doi: https://doi.org/10.1101/2020.05.11.20092916
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area